Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.
As of 18 November 2026, for the company name Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. as recorded, the chemical-drug catalogue lists 23 active records with this name as holder; 37 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
47 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Esomeprazole Magnesium Gastro-Resistant Tablets 1 records · Latest accepted 2026/11/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602785 | Generic | 2026/11/12 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Piperacillin Sodium for Injection 3 records · Latest accepted 2026/11/05
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602709 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHS2602708 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHS2602707 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Acetylcysteine Tablets 2 records · Latest accepted 2026/06/22
Generic · 2
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2026/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601269 | Generic | 2026/06/04 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
硫酸特布他林雾化吸入用溶液 · No verified English name 2 records · Latest accepted 2025/06/27
Supplement · 1Generic · 1
庆大霉素普鲁卡因维B12颗粒 · No verified English name 1 records · Latest accepted 2025/05/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501048 | Supplement | 2025/05/22 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | CDE ↗ |
庆大霉素普鲁卡因胶囊 · No verified English name 1 records · Latest accepted 2025/05/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501047 | Supplement | 2025/05/22 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | CDE ↗ |
Flumazenil Injection 3 records · Latest accepted 2025/04/03
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500663 | Supplement | 2025/04/03 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2500662 | Supplement | 2025/04/03 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2500661 | Supplement | 2025/04/03 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Rivaroxaban Tablets 3 records · Latest accepted 2025/01/14
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500108 | Supplement | 2025/01/14 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2500107 | Supplement | 2025/01/14 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2500106 | Supplement | 2025/01/14 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
硫唑嘌呤片 · No verified English name 1 records · Latest accepted 2024/12/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402069 | Supplement | 2024/12/06 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
布南色林片 · No verified English name 1 records · Latest accepted 2024/12/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404187 | Generic | 2024/12/04 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Procaterol Hydrochloride Solution for Inhalation 2 records · Latest accepted 2024/07/30
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402388 | Generic | 2024/07/30 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402387 | Generic | 2024/07/30 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Shandong Hua Lu Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Esomeprazole Magnesium Enteric-Coated Capsules 2 records · Latest accepted 2024/07/26
Generic · 2
Compound Ipratropium Bromide Solution For Inhalation 1 records · Latest accepted 2024/01/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400359 | Generic | 2024/01/26 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
青霉素皮试剂 · No verified English name 1 records · Latest accepted 2023/11/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302453 | Supplement | 2023/11/07 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Acetylcysteine Granules 3 records · Latest accepted 2023/11/04
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302438 | Supplement | 2023/11/04 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHS2101664 | Generic | 2021/08/30 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHS2101663 | Generic | 2021/08/30 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
注射用阿洛西林钠 · No verified English name 3 records · Latest accepted 2023/08/24
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301906 | Supplement | 2023/08/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2301905 | Supplement | 2023/08/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2301904 | Supplement | 2023/08/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Ipratropium Bromide Inhalation Solution 1 records · Latest accepted 2023/08/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302237 | Generic | 2023/08/23 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
吸入用吡非尼酮溶液 · No verified English name 2 records · Latest accepted 2023/03/08
New drug · 2
Acetylcysteine Solution For Inhalation 1 records · Latest accepted 2023/03/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300669 | Generic | 2023/03/02 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Kang En Bei Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Entecavir Tablets 2 records · Latest accepted 2022/08/22
Generic · 2
EVT-401片 · No verified English name 2 records · Latest accepted 2022/06/20
New drug · 2
Pirfenidone Tablets 1 records · Latest accepted 2022/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200634 | Generic | 2022/04/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2022/03/24
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250183 | Supplement | 2022/03/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2250182 | Supplement | 2022/03/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| CYHB2250181 | Supplement | 2022/03/24 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Azithromycin For Injection 1 records · Latest accepted 2021/11/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151038 | Supplement | 2021/11/25 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Acetylcysteine Effervescent Tablets 1 records · Latest accepted 2021/07/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150758 | Supplement | 2021/07/27 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Pantoprazole Sodium For Injection 1 records · Latest accepted 2021/02/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150107 | Supplement | 2021/02/09 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Parecoxib Sodium for Injection 1 records · Latest accepted 2021/01/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2140003 | Supplement | 2021/01/09 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 4 applications
- 2026/11/12Accepted
Esomeprazole Magnesium Gastro-Resistant Tablets
CYHS2602785
Fact date: 2026/11/12 · Date added to this site: 2026/11/13
View source ↗ - 2026/11/05Accepted
Piperacillin Sodium for Injection
CYHS2602709
Fact date: 2026/11/05 · Date added to this site: 2026/11/06
View source ↗ - 2026/11/05Accepted
Piperacillin Sodium for Injection
CYHS2602708
Fact date: 2026/11/05 · Date added to this site: 2026/11/06
View source ↗ - 2026/11/05Accepted
Piperacillin Sodium for Injection
CYHS2602707
Fact date: 2026/11/05 · Date added to this site: 2026/11/06
View source ↗
Under review
6 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Esomeprazole Magnesium Gastro-Resistant Tablets | CYHS2602785 | Generic | 2026/11/12 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Piperacillin Sodium for Injection | CYHS2602709 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Piperacillin Sodium for Injection | CYHS2602708 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Piperacillin Sodium for Injection | CYHS2602707 | Generic | 2026/11/05 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Acetylcysteine Tablets | CYHS2601460 | Generic | 2026/06/22 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| 复方匹可硫酸钠颗粒 · No verified English name | CYHS2601269 | Generic | 2026/06/04 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Catalogue holder records
23 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Rivaroxaban Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20213184 | 2026/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20269148 | 2026/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20269147 | 2026/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 布南色林片 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20264162 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20263385 | 2026/02/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Magnesium Enteric-Coated Capsules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20263386 | 2026/02/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Granules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20247184 | 2024/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20244570 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entecavir Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20244571 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20153285 | 2023/03/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20237028 | 2023/03/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20153293 | 2023/03/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin For Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20040447 | 2023/02/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acetylcysteine Granules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20223846 | 2022/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Effervescent Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20057334 | 2022/08/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pantoprazole Sodium For Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20153176 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Enteric Capsules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H19991118 | 2022/01/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Enteric Capsules | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20056062 | 2022/01/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20203115 | 2022/01/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20083793 | 2021/06/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Escitalopram Oxalate Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20130105 | 2021/04/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Escitalopram Oxalate Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20130106 | 2021/04/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | 国药准字H20213184 | 2021/03/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
37 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 阿奇霉素 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20260000882 | I | 2026/10/21 | CDE ↗ |
| 甲磺酸达比加群酯 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20260000651 | I | 2026/08/12 | CDE ↗ |
| 匹可硫酸钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20250000286 | A | 2026/11/04 | CDE ↗ |
| 泮托拉唑钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20240001303 | A | 2026/06/23 | CDE ↗ |
| 乙酰半胱氨酸 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20240001287 | A | 2026/06/02 | CDE ↗ |
| 布南色林 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20240000331 | A | 2025/09/23 | CDE ↗ |
| 氟马西尼 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20240000066 | A | 2025/11/03 | CDE ↗ |
| 他唑巴坦 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20230000592 | A | 2026/01/13 | CDE ↗ |
| 硫酸特布他林 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20230000539 | A | 2025/11/04 | CDE ↗ |
| 阿普米司特 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20230000393 | I | 2024/09/10 | CDE ↗ |
| 盐酸川芎嗪 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20210000905 | A | 2023/08/29 | CDE ↗ |
| 吡非尼酮 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20210000519 | A | 2023/05/25 | CDE ↗ |
| 异丙托溴铵 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20210000104 | A | 2025/11/04 | CDE ↗ |
| 奥美拉唑钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190009895 | A | 2024/01/27 | CDE ↗ |
| 奥美拉唑 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190008318 | A | 2025/08/29 | CDE ↗ |
| 氟氯西林钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190008265 | A | 2023/03/24 | CDE ↗ |
| 地红霉素 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007605 | A | 2024/05/10 | CDE ↗ |
| 那格列奈 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007572 | A | 2024/01/27 | CDE ↗ |
| 拉西地平 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007564 | A | 2025/01/11 | CDE ↗ |
| 盐酸坦索罗辛 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007563 | A | 2024/01/27 | CDE ↗ |
| 硫酸阿米卡星 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007561 | A | 2026/08/25 | CDE ↗ |
| 汉防己甲素 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007560 | A | 2025/11/21 | CDE ↗ |
| 帕米膦酸二钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007379 | A | 2023/08/30 | CDE ↗ |
| 盐酸吡格列酮 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190007352 | A | 2026/06/23 | CDE ↗ |
| 阿米卡星 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002822 | A | 2024/12/24 | CDE ↗ |
| 双氯芬酸钾 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002568 | A | — | CDE ↗ |
| 甲磺酸多沙唑嗪 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002529 | A | — | CDE ↗ |
| 单硫酸卡那霉素 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002495 | A | — | CDE ↗ |
| 磺胺甲噁唑 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002491 | A | — | CDE ↗ |
| 阿洛西林钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190002489 | A | — | CDE ↗ |
| 氨曲南 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190001228 | A | — | CDE ↗ |
| 奥美拉唑钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20190000386 | I | 2019/06/12 | CDE ↗ |
| 利伐沙班 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20180001075 | A | 2026/05/20 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20170000677 | A | 2022/10/19 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20170000667 | I | 2024/08/02 | CDE ↗ |
| 硫酸氢氯吡格雷 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20170000565 | A | 2024/07/31 | CDE ↗ |
| 恩替卡韦 · No verified English name | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | Y20170000402 | A | 2024/02/08 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
8 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Galantamine Hydrobromide Tablets | CYHS2600329 | Generic | 2026/01/31 | Hangzhou Kang En Bei Pharmaceutical Co., Ltd. romanized; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Galantamine Hydrobromide Tablets | CYHS2600328 | Generic | 2026/01/31 | Hangzhou Kang En Bei Pharmaceutical Co., Ltd. romanized; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| 瑞巴派特片 · No verified English name | CYHS2503083 | Generic | 2025/08/21 | Hangzhou Ao Mo Pharmaceuticals Co., Ltd. romanized; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| 拉西地平分散片 · No verified English name | CYHB2401907 | Supplement | 2024/11/16 | Zhong He Pharmaceuticals (Hubei) Co., Ltd. romanized; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| 青霉素皮试剂 · No verified English name | CYHB2400237 | Supplement | 2024/02/08 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| 瑞巴派特片 · No verified English name | CYHS2301236 | Generic | 2023/05/07 | Hangzhou Ao Mo Pharmaceuticals Co., Ltd. romanized; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Escitalopram Oxalate Tablets | CYHB2102091 | Supplement | 2021/11/03 | Zhejiang Haisen Pharmaceutical Co., Lt d.; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
| Escitalopram Oxalate Tablets | CYHB2102090 | Supplement | 2021/11/03 | Zhejiang Haisen Pharmaceutical Co., Lt d.; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.